Phase II Expansion Trial for Axitinib In Head And Neck Cancer
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Axitinib (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 30 Aug 2016 Status changed from not yet recruiting to recruiting.
- 17 Aug 2016 New trial record
- 11 Aug 2016 Planned initiation date changed from 1 May 2016 to 1 Sep 2016.